Revista de psiquiatria y salud mental最新文献

{"title":"Validation of a European Spanish adaptation of the Apathy Evaluation Scale-self-rated version (AES-S) in patients with schizophrenia","authors":"Clara Martínez-Cao ,&nbsp;Leticia García-Álvarez ,&nbsp;Teresa Bobes-Bascarán ,&nbsp;Lorena de la Fuente-Tomás ,&nbsp;Emilio Fernández-Egea ,&nbsp;Ángela Velasco ,&nbsp;Leticia González-Blanco ,&nbsp;Paula Zurrón-Madera ,&nbsp;Eduardo Fonseca-Pedrero ,&nbsp;Pilar A. Sáiz-Martínez ,&nbsp;María Paz García-Portilla ,&nbsp;Julio Bobes","doi":"10.1016/j.rpsm.2020.04.008","DOIUrl":"10.1016/j.rpsm.2020.04.008","url":null,"abstract":"<div><h3>Introduction</h3><p>Apathy is a negative symptom of schizophrenia and is associated with poor real world functioning. Therefore, it is important to have validated psychometric instruments to assess this symptom. This is the first study to validate the Spanish adaptation of the self-rated version of the Apathy Assessment Scale (AES-S) in patients with schizophrenia.</p></div><div><h3>Materials and methods</h3><p>Naturalistic, cross-sectional, validation study in 104 patients with schizophrenia evaluated using the following scales: Clinical Global Impression-Severity (CGI-S), Personal and Social Performance (PSP), Clinical Assessment Interview for Negative Symptoms (CAINS), Self-report of Negative Symptoms (SNS), Motivation and Pleasure Scale-Self-Report (MAP-SR), Calgary Depression Scale for Schizophrenia (CDSS), and Apathy Evaluation Scale-self-rated version (AES-S).</p></div><div><h3>Results</h3><p>Reliability: Internal consistency (Cronbach's alpha) was 0.908. Convergent validity: The Pearson correlation coefficient between AES-S and CAINS-MAP total scores was −0.483 (<em>p</em> <!-->&lt;<!--> <!-->0.001). For SNS, total and avolition subscale scores were −0.803 and −0.639 (<em>p</em> <!-->&lt;<!--> <!-->0.001), respectively. With the MAP-SR, the correlation coefficient was −0.727 (<em>p</em> <!-->&lt;<!--> <!-->0.001). Divergent validity: The Pearson correlation coefficient between AES-S and PSP total scores was 0.504 (<em>p</em> <!-->&lt;<!--> <!-->0.001). Furthermore, with the CDSS, the correlation coefficient was −0.431 (<em>p</em> <!-->&lt;<!--> <!-->0.001). Discriminant validity: The AES-S discriminated between different levels of illness severity according to CGI-S scores. Factor analysis: A three-component solution explained 57.32% of the variance. Pearson correlations between coefficients were 1–2<!--> <!-->=<!--> <!-->0.265, 1–3<!--> <!-->=<!--> <!-->0.464, and 2–3<!--> <!-->=<!--> <!-->0.060.</p></div><div><h3>Conclusion</h3><p>The Spanish AES-S is a reliable and valid instrument for assessing apathy in Spanish patients with schizophrenia. It seems to be appropriate for use in everyday clinical practice as a means of monitoring apathy in these patients.</p></div>","PeriodicalId":21391,"journal":{"name":"Revista de psiquiatria y salud mental","volume":"15 1","pages":"Pages 22-28"},"PeriodicalIF":9.2,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S1888989120300331/pdfft?md5=3d48a2cba476908b299b235cf261095d&pid=1-s2.0-S1888989120300331-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"38017848","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Efectos del trauma infantil en el reconocimiento de la expresión facial de miedo en psicosis","authors":"Antía Brañas ,&nbsp;Guillermo Lahera ,&nbsp;María Luisa Barrigón ,&nbsp;Manuel Canal-Rivero ,&nbsp;Miguel Ruiz-Veguilla","doi":"10.1016/j.rpsm.2019.01.005","DOIUrl":"10.1016/j.rpsm.2019.01.005","url":null,"abstract":"<div><h3>Introduction</h3><p>Childhood trauma has been reported as a risk factor for psychosis. Different types of traumatic experiences in childhood could lead to different clinical manifestations in psychotic disorders.</p></div><div><h3>Material and methods</h3><p>We studied differences in social cognition (emotion recognition and theory of mind) and clinical symptoms in a sample of 62 patients with psychosis (less than 5 years of illness) and childhood trauma, analysing performance by trauma type.</p></div><div><h3>Results</h3><p>Psychotic patients with a history of childhood trauma other than sexual abuse were more capable of recognizing fear as a facial emotion (especially when facial stimuli were non-degraded) than participants with a history of sexual abuse or with no history of childhood trauma (<em>P</em> <!-->=<!--> <!-->.008). We also found that the group that had suffered sexual abuse did not show improvement in fear recognition when exposed to clearer stimuli, although this intergroup difference did not reach statistical significance (<em>P</em> <!-->=<!--> <!-->.064). We have not found other differences between abuse groups, neither in clinical symptoms (PANSS factors) nor in Hinting Task scores.</p></div><div><h3>Conclusion</h3><p>We have found differences in fear recognition among patients with psychotic disorders who have experienced different types of childhood trauma.</p></div>","PeriodicalId":21391,"journal":{"name":"Revista de psiquiatria y salud mental","volume":"15 1","pages":"Pages 29-37"},"PeriodicalIF":9.2,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S1888989119300229/pdfft?md5=572c81690f35521be63261a0dc5b25cf&pid=1-s2.0-S1888989119300229-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"37231997","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"[Suicidal attempt and suicidal ideation during the COVID-19 pandemic compared to previous years].","authors":"Miguel A Jerónimo, Sergio Piñar, Pilar Samos, Ana M Gonzalez, Magda Bellsolà, Agnès Sabaté, Jordi León, Xavier Aliart, Luis M Martín, Rosa Aceña, Victor Pérez, David Córcoles","doi":"10.1016/j.rpsm.2021.11.004","DOIUrl":"10.1016/j.rpsm.2021.11.004","url":null,"abstract":"<p><strong>Introduction: </strong>Since the COVID-19 pandemic began, warnings have been made about the impact on the mental health of the population and as occurred in previous pandemics, an increase in suicide rates had been anticipated. To date, studies differ with regard to whether suicide rates are being affected during the COVID pandemic.</p><p><strong>Material and methods: </strong>All individuals registered for suicidal ideation or suicidal attempt in the Suicide Risk Code (CRS) from the city of Barcelona from January 1, 2018 to June 30, 2021 have been included. A bivariate analysis has been carried out between the 2018-2019 period and the pandemic period. The percentage increase in the monthly incidence of CRS cases has been calculated, using the average monthly incidence for the 2018-2019 period as a reference.</p><p><strong>Results: </strong>A total of 3388 consultations for suicide ideation or suicidal attempt were registered. There has been an increase of 43.20% in the monthly incidence of suicidal ideation and suicidal attempts during the pandemic compared to the 2018-2019 period, reaching a maximum increase of 573.8% in young people under 18 years in the month of May 2021.</p><p><strong>Conclusions: </strong>During the COVID-19 pandemic period, consultations for suicidal ideation and suicidal attempts have increased compared to the previous 2 years in the city of Barcelona. It should be noted this growth especially in young people under 18 years.</p>","PeriodicalId":21391,"journal":{"name":"Revista de psiquiatria y salud mental","volume":" ","pages":""},"PeriodicalIF":9.2,"publicationDate":"2021-11-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8603872/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9589183","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"La Convención de Naciones Unidas sobre los Derechos de las Personas con Discapacidad: los efectos del debate","authors":"Julián Gómez Peñalver,&nbsp;Carmen Fernández de Henestrosa Serra,&nbsp;José Luis Ayuso-Mateos","doi":"10.1016/j.rpsm.2021.02.001","DOIUrl":"10.1016/j.rpsm.2021.02.001","url":null,"abstract":"","PeriodicalId":21391,"journal":{"name":"Revista de psiquiatria y salud mental","volume":"14 4","pages":"Pages 230-231"},"PeriodicalIF":9.2,"publicationDate":"2021-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S1888989121000276/pdfft?md5=1757b7377c6dcdb8e82eefd1215b814b&pid=1-s2.0-S1888989121000276-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"25365641","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Exploring the factor structure of the mini-ICF-APP in an inpatient clinical sample, according to the psychiatric diagnosis","authors":"Stephan T. Egger ,&nbsp;Godehard Weniger ,&nbsp;Julio Bobes ,&nbsp;Erich Seifritz ,&nbsp;Stefan Vetter","doi":"10.1016/j.rpsm.2020.05.008","DOIUrl":"10.1016/j.rpsm.2020.05.008","url":null,"abstract":"<div><h3>Introduction</h3><p>Psychosocial functioning is a key factor determining prognosis, severity, impairment and quality of life in people who have a mental disorder. The mini-ICF-APP was developed to provide a standardised classification of functioning and disability. However, despite its gaining popularity little is known about its structure and performance. This paper examines the structure of the mini-ICF-APP using factor analysis techniques.</p></div><div><h3>Materials and methods</h3><p>In a clinical sample of 3178 patients, with psychiatric diagnoses from several ICD-10 categories, we analysed internal consistency, item inter-correlations and the factorial structure of the data, with reference to ICD-10 diagnostic categories; Neurocognitive Disorders; Alcohol Use Disorders; Substance Use Disorders; Schizophrenia and Psychotic Disorders; Bipolar Disorder; Major Depressive Disorder; Anxiety Disorders; Personality Disorders; and Neurodevelopmental Disorders.</p></div><div><h3>Results</h3><p>We found good internal consistency and item inter-correlations (Cronbach alpha<!--> <!-->=<!--> <!-->0.92) for the mini-ICF-APP. We were able to identify pivotal domains (flexibility, assertiveness and intimate relationships), which demonstrate sub-threshold influences on other domains. The factor analysis yielded a one-factor model as ideal for the whole sample and for all diagnostic categories. For some diagnostic categories the data suggested a two or three-factor model, however, with poorer fit indices.</p></div><div><h3>Conclusions</h3><p>The factor structure of the mini-ICF-APP appears to modify according to the main diagnosis. However, a one-factor model demonstrates better fit regardless of diagnostic category. Consequently, we consider the mini-ICF-APP to be a trans-diagnostic measurement instrument for the assessment and grading of psychosocial functioning. The use of the mini-ICF-APP sum score seems to best reflect the degree of impairment in an individual, even taking into account that affected domains may lead to sub-threshold effects on other domains.</p></div>","PeriodicalId":21391,"journal":{"name":"Revista de psiquiatria y salud mental","volume":"14 4","pages":"Pages 186-195"},"PeriodicalIF":9.2,"publicationDate":"2021-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S1888989120300665/pdfft?md5=8b5ff36bfd2f96489e0da5d926b2ec13&pid=1-s2.0-S1888989120300665-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"38200551","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Obsessive–compulsive symptoms in anxiety and depressive disorders: Influence of recent and/or traumatic life events","authors":"Arantxa Orozco ,&nbsp;Narcís Cardoner ,&nbsp;Cristina F. Aragón ,&nbsp;Salvador Ruiz-Murugarren ,&nbsp;María Vicens ,&nbsp;Miguel Ángel Álvarez-Mon ,&nbsp;Guillermo Lahera","doi":"10.1016/j.rpsm.2020.12.002","DOIUrl":"10.1016/j.rpsm.2020.12.002","url":null,"abstract":"<div><h3>Introduction</h3><p>A high prevalence of obsessive–compulsive symptoms (OCSs) in anxiety-depressive disorders ranging from 30 to 67% has been described.</p></div><div><h3>Objective</h3><p>This study aims to assess the presence and persistence of OCSs in an outpatient sample of subjects with anxiety and depressive disorders, as well as its relationship with recent life events (RLEs) and/or traumatic experiences (TEs).</p></div><div><h3>Method</h3><p>We conducted a prospective, observational, analytical study of 200 subjects with DSM-5 diagnoses of anxiety and/or depression. Participants were included by consecutive sampling and were evaluated at baseline and after 6–12 months (mean 8.5 months) of follow-up. The severity of the symptoms was assessed through the Hamilton Anxiety Scale (HARS) and Hamilton Scale for the evaluation of depression (HRSD-17), and comorbidity was assessed through the International Neuropsychiatric Interview (MINI). The Revised Inventory of Obsessions and Compulsions (OCI-R), the Recent Vital Changes Questionnaire (CVSV), and the Diagnostic Scale for Post-Traumatic Stress (PDS) were also administered.</p></div><div><h3>Results</h3><p>54% of the sample presented OCSs, and 30.5% presented one or more TEs throughout life. At the baseline visit, the presence of OCSs was associated with the severity of depressive symptoms (<em>p</em> <!-->=<!--> <!-->0.028), the presence of TEs (<em>p</em> <!-->&lt;<!--> <!-->0.01), symptoms of post-traumatic stress disorder (<em>p</em> <!-->&lt;<!--> <!-->0.01) and the number of RLEs (<em>p</em> <!-->&lt;<!--> <!-->0.01). Response rate at follow-up was 38%, and persistence of OCSs was found in 60.5% of patients, independent of depressive or anxious symptoms, but was associated with the number of RLEs (<em>p</em> <!-->&lt;<!--> <!-->0.01).</p></div><div><h3>Conclusion</h3><p>The presence of OCSs in patients with anxiety and depressive disorders is frequent and persistent. Anxious-depressive patients with a history of TEs and RLEs had higher OCS levels. These findings highlight the importance of early detection and the use of therapeutic strategies focused on resilience to stress and trauma.</p></div>","PeriodicalId":21391,"journal":{"name":"Revista de psiquiatria y salud mental","volume":"14 4","pages":"Pages 218-226"},"PeriodicalIF":9.2,"publicationDate":"2021-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S1888989120301294/pdfft?md5=8d2551f4d35f931ee739ef08de16ca08&pid=1-s2.0-S1888989120301294-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"38747424","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"The probability of response after each subcutaneous injection of esketamine in treatment-resistant depression","authors":"Victor Augusto Rodovalho Fava ,&nbsp;Luciana Maria Sarin ,&nbsp;Ana Cecília Lucchese ,&nbsp;Lorena Del Sant ,&nbsp;Eduardo Magalhães ,&nbsp;Rodrigo Simonini Delfino ,&nbsp;Marco Aurélio Tuena ,&nbsp;Carolina Nakahira ,&nbsp;Andrea Parolin Jackowski ,&nbsp;Guilherme Abdo ,&nbsp;Juliana Surjan ,&nbsp;Matheus Steiglich ,&nbsp;Matheus Ghossain Barbosa ,&nbsp;José Alberto Del Porto ,&nbsp;Acioly Luiz Tavares Lacerda ,&nbsp;Hugo Cogo-Moreira","doi":"10.1016/j.rpsm.2020.10.003","DOIUrl":"10.1016/j.rpsm.2020.10.003","url":null,"abstract":"<div><h3>Introduction</h3><p>The administration of multiple esketamine doses has shown efficacy for unipolar and bipolar treatment-resistant depression (TRD). Nevertheless, the probability of responding or not after each dose in the real-world remains unknown. This study aimed to estimate it throughout four doses of esketamine, administrated via subcutaneous (SC).</p></div><div><h3>Material and methods</h3><p>We conducted a retrospective analysis of a case series of 70 patients with TRD who received treatment from the esketamine assistance program at Federal University of Sao Paulo, between April 2017 and December 2018. The SC injections were administrated weekly at a dose of 0.5–1.0<!--> <!-->mg/kg, in conjunction with patients’ psychotropic drugs. Response was defined as a decrease of at least 50% in the Montgomery-Åsberg Depression Rating Scale between baseline and 24<!--> <!-->h after dose. We used hidden Markov modeling in order to estimate de probability of response after each esketamine injection.</p></div><div><h3>Results</h3><p>The probability of a patient that was a “non-responder” to become a “responder” following a SC injection of esketamine was 17.30% and the probability that this patient remains a “non-responder” was 82.70%. The probability of a patient that was a “responder” to remain as a “responder” was 95%.</p></div><div><h3>Conclusions</h3><p>Patients with TRD who had not responded after the first dose of esketamine, still had a chance of responding after the subsequent dose administrated via SC.</p></div>","PeriodicalId":21391,"journal":{"name":"Revista de psiquiatria y salud mental","volume":"14 4","pages":"Pages 212-217"},"PeriodicalIF":9.2,"publicationDate":"2021-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S1888989120301178/pdfft?md5=8b99e6d2b06dcf3a387f454ce0eb0ade&pid=1-s2.0-S1888989120301178-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"38505659","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"¿Los pacientes psiquiátricos son más vulnerables ante la ley de la eutanasia española?","authors":"Adrián Alacreu-Crespo ,&nbsp;Lucas Giner ,&nbsp;Philippe Courtet","doi":"10.1016/j.rpsm.2021.01.003","DOIUrl":"10.1016/j.rpsm.2021.01.003","url":null,"abstract":"","PeriodicalId":21391,"journal":{"name":"Revista de psiquiatria y salud mental","volume":"14 4","pages":"Pages 231-233"},"PeriodicalIF":9.2,"publicationDate":"2021-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S1888989121000203/pdfft?md5=55aafbb6bfaa1c703336e0bf0050eac0&pid=1-s2.0-S1888989121000203-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"38867223","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Sensibilidad y especificidad de los criterios diagnósticos DSM-5 en el trastorno del espectro autista en una muestra de niños y adolescentes españoles","authors":"Ana Blázquez Hinojosa ,&nbsp;Luisa Lázaro Garcia ,&nbsp;Olga Puig Navarro ,&nbsp;Eva Varela Bondelle ,&nbsp;Rosa Calvo Escalona","doi":"10.1016/j.rpsm.2019.10.004","DOIUrl":"10.1016/j.rpsm.2019.10.004","url":null,"abstract":"<div><h3>Background</h3><p>Controversy exists regarding the DSM-5 criteria for autism spectrum disorders (ASD). Given the mixed results that have been reported, our main aim was to determine DSM-5 sensitivity and specificity in a child and adolescent Spanish sample. As secondary goals, we assessed the diagnostic stability of DSM-IV-TR in DSM-5, and clinical differences between children diagnosed with an ASD or a social (pragmatic) communication disorder (SPCD).</p></div><div><h3>Methods</h3><p>This study was carried out in 2017, reviewing the medical records of patients evaluated in our service. Items from a parent report measure of ASD symptoms (Autism Diagnostic Interview-Revised) were matched to DSM-5 criteria and used to assess the sensitivity and specificity of the DSM-5 criteria and current DSM-IV criteria when compared with clinical diagnoses.</p></div><div><h3>Results</h3><p>DSM-5 sensitivity ranged from 0.69 to 1.00, and was higher in females. By age, the DSM-5 and DSM-IV-TR criteria showed similar sensitivity. In the case of intellectual quotient, DSM-5 criteria sensitivity was lower for those in the “low-functioning” category. DSM-5 specificity ranged from 0.64 to 0.73, while DSM-5 specificity was similar for all phenotypic subgroups. With respect to stability, 83.3% of autism disorder cases retained a diagnosis of ASD using the DSM-5 criteria. With regard to differences between ASD and SPCD, we found that patients diagnosed with ASD received more pharmacological treatment than those diagnosed with SPCD.</p></div><div><h3>Conclusions</h3><p>Further research is required to confirm our results. Studies focusing on the SPCD phenotype will be necessary to determine outcome differences with ASD and the most effective diagnostic and therapeutic tools.</p></div>","PeriodicalId":21391,"journal":{"name":"Revista de psiquiatria y salud mental","volume":"14 4","pages":"Pages 202-211"},"PeriodicalIF":9.2,"publicationDate":"2021-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S1888989119300990/pdfft?md5=79259de42c79d30e7bf5bb92caa7ab58&pid=1-s2.0-S1888989119300990-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"37480791","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Intoxicación por litio: la amenaza SILENTiosa","authors":"Álvaro Martínez-Martín ,&nbsp;Álvaro Sánchez-Larsen ,&nbsp;Carolina Sánchez-Mora ,&nbsp;Rocío Sáez-Povedano ,&nbsp;Tomás Segura","doi":"10.1016/j.rpsm.2020.06.006","DOIUrl":"10.1016/j.rpsm.2020.06.006","url":null,"abstract":"","PeriodicalId":21391,"journal":{"name":"Revista de psiquiatria y salud mental","volume":"14 4","pages":"Pages 233-234"},"PeriodicalIF":9.2,"publicationDate":"2021-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S1888989120300756/pdfft?md5=7c639bb6920c68b54166d7a59b8be2a0&pid=1-s2.0-S1888989120300756-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"38200848","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}